Making moves: Civica, Astellas, Inozyme and more announce key new hires

Civica taps COO Ned McCoy to succeed Martin VanTrieste as CEO amid push to develop low-cost insulin Civica CEO Ned McCoy Permission granted by Civica. Who: Long-time Civica chief operating officer Ned McCoy took the helm of the nonprofit generic drug company June 1, succeeding former President and CEO Martin VanTrieste. Background: McCoy brings an … Read more

Making moves: Inovio, Veru, MindMed and more announce key new hires

Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Veru appoints new head of its US Infectious Disease Franchise ahead of potential COVID-19 EUA Joel Batten, executive vice president of Veru’s infectious disease franchise Retrieved from Veru Inc. on May 25, 2022 Who: Joel Batten joined … Read more

Real-world data is making drug development more true to life

Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Real-world data (RWD) has long played a supporting role in the pharma industry, primarily acting as a monitor for post-approval drug safety. Now, drugmakers are looking to save time and money using the data in new, more … Read more